Flu

New Webinar: Coding, Coverage, and Reimbursement for Sanofi Vaccines and Immunizations

We are happy to share that Sanofi is offering a complimentary 60-minute webinar on coding, coverage, and reimbursement for Flublok® (Influenza Vaccine), Fluzone® High-Dose (Influenza Vaccine), Fluzone® (Influenza Vaccine), Beyfortus® (nirsevimab-alip) and Nuvaxovid™ (COVID-19 Vaccine, Adjuvanted). Sanofi believes that your attendance at this webinar will leave you well informed of the payer landscape and better prepared to begin coding and billing for these immunizations.

This webinar will cover several important topics, including:

• The National Reimbursement Landscape

• Proper Coding

• Benchmarking Charge and Payment Amounts

• Annual Payer Updates and Purchase to Payment Timeline

• Resources to Assist You with Coding, Billing & Payment

Please click the “Register Here” button below to register for this complimentary webinar.  There are 8 live sessions to choose from, each include a presentation followed by a live Q&A. Registration will only take a few moments and you will then receive a non-shareable link to use to join the program.  You will also receive a reminder message one day prior to and the day of the webinar. 

Please be sure to register today! 

Available July 1: the first over-the-counter test that offers fast and accurate testing for both COVID-19 and Flu A/B

Beginning July 1, 2024, the LUCIRA by Pfizer COVID-19 & Flu Test will be available to order for all PRN members. This cordless device gives you results in 30 minutes, showing a positive result in as few as 11 minutes.

LUCIRA by Pfizer COVID-19 and Flu A & B test offers the convenience of an in-office test with molecular testing and PCR-quality accuracy for ages 2 and up.

Swab, stir and detect. 3 simple steps with an easy-to-read display. Click on the image below for more details.